Creso Pharma |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 7:13pm | ||||
|
Market Cap (14-Nov) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Trading Halt
CPH released this announcement to the ASX on 16 June 2021, 9:42. The announcement is marked as price sensitive, and is 2 page(s) in length and 141.77kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.789% short sold according to ASIC data. It was ranked the 203rd most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Trading Halt | 16 June 2021, 9:42 |
| Creso Pharma completes US OTC dual listing | 11 June 2021, 9:25 |
| Halucenex Expands its Clinical Trials Plans | 8 June 2021, 9:26 |
| Distribution Agreement Expanded to Cover 14 Countries | 4 June 2021, 9:47 |
If you were already registered, log in here.